116 related articles for article (PubMed ID: 38556072)
21. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
22. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
23. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
[TBL] [Abstract][Full Text] [Related]
25. Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.
Heller C; Weisser T; Mueller-Schickert A; Rufer E; Hoh A; Leonhardt RM; Knittler MR
J Biol Chem; 2011 Apr; 286(13):10983-97. PubMed ID: 21321113
[TBL] [Abstract][Full Text] [Related]
26. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
[TBL] [Abstract][Full Text] [Related]
27. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract][Full Text] [Related]
29. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
30. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
Nor Rashid N; Yusof R; Watson RJ
J Gen Virol; 2011 Nov; 92(Pt 11):2620-2627. PubMed ID: 21813705
[TBL] [Abstract][Full Text] [Related]
31. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
32. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
34. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells.
Muñoz JP; González C; Parra B; Corvalán AH; Tornesello ML; Eizuru Y; Aguayo F
PLoS One; 2012; 7(5):e38178. PubMed ID: 22662279
[TBL] [Abstract][Full Text] [Related]
37. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
38. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
Mazumder Indra D; Singh RK; Mitra S; Dutta S; Chakraborty C; Basu PS; Mondal RK; Roychoudhury S; Panda CK
Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249
[TBL] [Abstract][Full Text] [Related]
39. Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.
Xu J; Liu H; Yang Y; Wang X; Liu P; Li Y; Meyers C; Banerjee NS; Wang HK; Cam M; Lu W; Chow LT; Xie X; Zhu J; Zheng ZM
mBio; 2019 Jan; 10(1):. PubMed ID: 30696738
[TBL] [Abstract][Full Text] [Related]
40. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
Mikuličić S; Shamun M; Massenberg A; Franke AL; Freitag K; Döring T; Strunk J; Tenzer S; Lang T; Florin L
Front Immunol; 2024; 15():1335302. PubMed ID: 38370412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]